LULUJune 8, 2026 at 9:51 AM UTCConsumer Durables & Apparel

LULU Guidance Cut Confirms North America Deterioration; Margin Pressure Persists

Read source article

What happened

Lululemon's Q1 FY2026 earnings reinforced the bearish narrative as the company cut its full-year outlook amid persistently weak North America demand. Revenue rose just 4% to $2.5B, but Americas comparable sales fell 5% and gross margin plunged 410 bps to 54.2%, driven by markdowns, inventory provisions, and tariffs. Management acknowledged negative brand commentary and weak product launches, while accelerating product cycles and international expansion to offset the slump. The guidance reduction to $11.0B–$11.15B revenue and $10.95–$11.15 EPS underscores that the recovery is not self-sustaining, and the leadership transition to a new CEO on Sept 8 adds further uncertainty. Despite the stock trading at a low 9.9x P/E, the operating deterioration and lack of near-term catalysts suggest the risk is to the downside.

Implication

The guidance cut and persistent margin compression reinforce the bear-case scenario (25% probability, $105 target). Valuation at 9.9x P/E is optically cheap but justified by weakening earnings power and structural challenges. International growth (22% in Q1) provides a partial offset but cannot fully compensate for North America's decline, which generates ~70% of revenue. Key catalysts to watch: Q2 FY2026 results (due early September) must show no further guidance cuts and narrowing gross margin declines, while the incoming CEO must deliver a credible stabilization plan. Until then, the risk skew is negative, and the attractive entry point of $115 remains the preferred re-entry zone.

Thesis delta

The Q1 report and guidance cut increase the probability of the bear case (now above 25%) and push back expectations for a North America turnaround. The thesis now assumes Americas comps may remain negative through at least Q3 FY2026, with gross margin unlikely to stabilize before the holiday quarter. The leadership transition adds execution risk, making the base case ($130) less likely in the near term.

Confidence

High